CHANNELS

Aerospace

Automotive

Automated & Autonomous Vehicles

Battery & Electrification Technology

Defense

Electronics

Manufacturing & Prototyping

Materials

Medical

Motion Control

Photonics

RF & Microwave Technology

Robotics & Automation

Sensors & IoT

Test & Measurement

Aerospace
Automotive
Automated & Autonomous Vehicles
Battery & Electrification Technology
Defense
Electronics
Manufacturing & Prototyping
Materials
Medical
Motion Control
Photonics
RF & Microwave Technology
Robotics & Automation
Sensors & IoT
Test & Measurement
Aerospace & Defense
Search Results

Immunotherapy: Drug Harnesses Immune System Against Cancer

Certain types of immune cells called regulatory T-cells, while vital for a balanced immune system, can hinder the cancer-killing process. Targeting these cells without affecting other immune cells in the past has been difficult. A new drug can stop regulatory T-cells from working while leaving other immune cells intact to fight the cancer cells. Watch this drug in action in this short animation. “TIL therapy shifts the power back to the immune system to overcome the abnormal microenvironment inside a tumor that allows the cancer to grow unchecked by the immune system,” said Kai He, MD, PhD  .

Topics:
Medical

More From SAE Media Group

Medical Design Briefs INSIDER
Implantable Uses Light to Treat Cancers
Related Article Image
Medical Design Briefs
Moving the Needle on Monitoring Skin Cancer
Related Article Image
Medical Design Briefs
Cold Plasma Patch Could Make Immunotherapy More Effective for Treating Melanoma
Related Article Image
Tech Briefs
Miniature Optical Fiber Treatment Device Offers More Effective Cancer Immunotherapy
Related Article Image